Drug Use Investigation of Gadovist

Trial Profile

Drug Use Investigation of Gadovist

Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2017

At a glance

  • Drugs Gadobutrol (Primary)
  • Indications Breast cancer; Vascular disorders
  • Focus Adverse reactions
  • Sponsors Bayer
  • Most Recent Events

    • 26 Sep 2017 Planned primary completion date changed from 15 Sep 2017 to 15 Sep 2018.
    • 27 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 28 Sep 2015 Planned initiation date changed from 1 Sep 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top